Replicate Bioscience Funding & Investors
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of drug resistance and create solutions that enhance the effectiveness of many immuno-oncology regimens.
replicatebioscience.comTotal Amount Raised: $46,000,000
Replicate Bioscience Funding Rounds
Series A
$40,000,000
Series A Investors
Apple Tree PartnersSeed
$6,000,000
Seed Investors
Apple Tree Partners
Funding info provided by Diffbot.